Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 859 entries
Sorted by: Best Match Show Resources per page
Informal health and education sector payments in Russian and Ukrainian cities: Structuring welfare from below

informal education

Morris J, Polese A.
GSID: PXTx0pCaBFwJ
J Morris, A Polese - European Urban and Regional Studies, 2016 - journals.sagepub.com

… In both Russia and Ukraine the pay of higher education instructors and many types of health professional is very low. We introduce a … moral understanding of informal payments in education and health. We show that in the...

Cite
Morris, J., & Polese, A. (2016). Informal health and education sector payments in Russian and Ukrainian cities: Structuring welfare from below. European Urban and Regional Studies, 23(3), 481-496.
Morris, Jeremy, and Abel Polese. "Informal health and education sector payments in Russian and Ukrainian cities: Structuring welfare from below." European Urban and Regional Studies 23.3 (2016): 481-496.
Copy Download .nbib Format: MLA
Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity.

Cell metabolism

Kazak L, Chouchani ET, Lu GZ, Jedrychowski MP, Bare CJ, Mina AI, Kumari M, Zhang S, Vuckovic I, Laznik-Bogoslavski D, Dzeja P, Banks AS, Rosen ED, Spiegelman BM.
PMID: 28978428
Cell Metab. 2017 Oct 03;26(4):693. doi: 10.1016/j.cmet.2017.09.007.

No abstract available.

Cite
Kazak L, Chouchani ET, Lu GZ, et al. Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity. Cell Metab. 2017;26(4):693doi: 10.1016/j.cmet.2017.09.007.
Kazak, L., Chouchani, E. T., Lu, G. Z., Jedrychowski, M. P., Bare, C. J., Mina, A. I., Kumari, M., Zhang, S., Vuckovic, I., Laznik-Bogoslavski, D., Dzeja, P., Banks, A. S., Rosen, E. D., & Spiegelman, B. M. (2017). Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity. Cell metabolism, 26(4), 693. https://doi.org/10.1016/j.cmet.2017.09.007
Kazak, Lawrence, et al. "Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity." Cell metabolism vol. 26,4 (2017): 693. doi: https://doi.org/10.1016/j.cmet.2017.09.007
Kazak L, Chouchani ET, Lu GZ, Jedrychowski MP, Bare CJ, Mina AI, Kumari M, Zhang S, Vuckovic I, Laznik-Bogoslavski D, Dzeja P, Banks AS, Rosen ED, Spiegelman BM. Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity. Cell Metab. 2017 Oct 03;26(4):693. doi: 10.1016/j.cmet.2017.09.007. PMID: 28978428; PMCID: PMC5638127.
Copy Download .nbib Format: NLM
USES AND LIMITATIONS OF ELECTROPHYSIOLOGY WITH HEARING AIDS.

Seminars in hearing

Billings CJ.
PMID: 28979063
Semin Hear. 2013 Nov;34(4):257-269. doi: 10.1055/s-0033-1356638.

There is currently a strong interest among both audiologists and hearing researchers to find a physiological measure that can be used as a marker of how amplified sounds are processed by the brain (i.e., hearing aid fitting) or how...

Cite
Billings CJ. USES AND LIMITATIONS OF ELECTROPHYSIOLOGY WITH HEARING AIDS. Semin Hear. 2013;34(4):257-269doi: 10.1055/s-0033-1356638.
Billings, C. J. (2013). USES AND LIMITATIONS OF ELECTROPHYSIOLOGY WITH HEARING AIDS. Seminars in hearing, 34(4), 257-269. https://doi.org/10.1055/s-0033-1356638
Billings, Curtis J. "USES AND LIMITATIONS OF ELECTROPHYSIOLOGY WITH HEARING AIDS." Seminars in hearing vol. 34,4 (2013): 257-269. doi: https://doi.org/10.1055/s-0033-1356638
Billings CJ. USES AND LIMITATIONS OF ELECTROPHYSIOLOGY WITH HEARING AIDS. Semin Hear. 2013 Nov;34(4):257-269. doi: 10.1055/s-0033-1356638. PMID: 28979063; PMCID: PMC5624799.
Copy Download .nbib Format: NLM
Validity of Ratings of Perceived Exertion in Patients with Type 2 Diabetes.

Journal of novel physiotherapy and physical rehabilitation

Unick JL, Gaussoin S, Bahnson J, Crow R, Curtis J, Killean T, Regensteiner JG, Stewart KJ, Wing RR, Jakicic JM.
PMID: 25485308
J Nov Physiother Phys Rehabil. 2014 Jul 07;1(1).

PURPOSE: To examine whether a subjective measure of moderate-intensity exercise (12-13 on Borg's ratings of perceived exertion scale; RPE) corresponds to the target heart rate for moderate-intensity exercise (40-59% heart rate reserve; %HRR) and to determine the characteristics of...

Cite
Unick JL, Gaussoin S, Bahnson J, et al. Validity of Ratings of Perceived Exertion in Patients with Type 2 Diabetes. J Nov Physiother Phys Rehabil. 2014;1(1)
Unick, J. L., Gaussoin, S., Bahnson, J., Crow, R., Curtis, J., Killean, T., Regensteiner, J. G., Stewart, K. J., Wing, R. R., Jakicic, J. M. (2014). Validity of Ratings of Perceived Exertion in Patients with Type 2 Diabetes. Journal of novel physiotherapy and physical rehabilitation, 1(1), .
Unick, Jessica L, et al. "Validity of Ratings of Perceived Exertion in Patients with Type 2 Diabetes." Journal of novel physiotherapy and physical rehabilitation vol. 1,1 (2014).
Unick JL, Gaussoin S, Bahnson J, Crow R, Curtis J, Killean T, Regensteiner JG, Stewart KJ, Wing RR, Jakicic JM. Validity of Ratings of Perceived Exertion in Patients with Type 2 Diabetes. J Nov Physiother Phys Rehabil. 2014 Jul 07;1(1). PMID: 25485308; PMCID: PMC4255703.
Copy Download .nbib Format: NLM
The expanding role of pertuzumab in the treatment of HER2-positive breast cancer.

Breast cancer (Dove Medical Press)

Moya-Horno I, Cortés J.
PMID: 26056489
Breast Cancer (Dove Med Press). 2015 May 21;7:125-32. doi: 10.2147/BCTT.S61579. eCollection 2015.

Breast cancer tumors that demonstrate gene amplification or overexpression of human epidermal growth factor receptor 2 (HER2) are classified as HER2-positive. They account for approximately 15% of all breast cancers and represent an adverse prognostic factor. Over the past...

Cite
Moya-Horno I, Cortés J. The expanding role of pertuzumab in the treatment of HER2-positive breast cancer. Breast Cancer (Dove Med Press). 2015;7:125-32doi: 10.2147/BCTT.S61579.
Moya-Horno, I., & Cortés, J. (2015). The expanding role of pertuzumab in the treatment of HER2-positive breast cancer. Breast cancer (Dove Medical Press), 7125-32. https://doi.org/10.2147/BCTT.S61579
Moya-Horno, I, and Cortés, J. "The expanding role of pertuzumab in the treatment of HER2-positive breast cancer." Breast cancer (Dove Medical Press) vol. 7 (2015): 125-32. doi: https://doi.org/10.2147/BCTT.S61579
Moya-Horno I, Cortés J. The expanding role of pertuzumab in the treatment of HER2-positive breast cancer. Breast Cancer (Dove Med Press). 2015 May 21;7:125-32. doi: 10.2147/BCTT.S61579. eCollection 2015. PMID: 26056489; PMCID: PMC4445592.
Copy Download .nbib Format: NLM
Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain: Health Resource Utilization and Labour Absenteeism.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Cortés J, Andreu JL, Calvo J, García-Aparicio AM, Coronell CG, Díaz-Cerezo S.
PMID: 27201706
Value Health. 2014 Nov;17(7):A534. doi: 10.1016/j.jval.2014.08.1703. Epub 2014 Oct 26.

No abstract available.

Cite
Cortés J, Andreu JL, Calvo J, et al. Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain: Health Resource Utilization and Labour Absenteeism. Value Health. 2014;17(7):A534doi: 10.1016/j.jval.2014.08.1703.
Cortés, J., Andreu, J. L., Calvo, J., García-Aparicio, A. M., Coronell, C. G., & Díaz-Cerezo, S. (2014). Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain: Health Resource Utilization and Labour Absenteeism. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A534. https://doi.org/10.1016/j.jval.2014.08.1703
Cortés, J, et al. "Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain: Health Resource Utilization and Labour Absenteeism." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A534. doi: https://doi.org/10.1016/j.jval.2014.08.1703
Cortés J, Andreu JL, Calvo J, García-Aparicio AM, Coronell CG, Díaz-Cerezo S. Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain: Health Resource Utilization and Labour Absenteeism. Value Health. 2014 Nov;17(7):A534. doi: 10.1016/j.jval.2014.08.1703. Epub 2014 Oct 26. PMID: 27201706.
Copy Download .nbib Format: NLM
Young Age at Diagnosis of Type 1 Diabetes Is Associated with the Development of Celiac Disease-Associated Antibodies in Children Living in Newfoundland and Labrador, Canada.

Children (Basel, Switzerland)

Pall H, Newhook LA, Aaron H, Curtis J, Randell E.
PMID: 27417372
Children (Basel). 2015 Oct 14;2(4):403-11. doi: 10.3390/children2040403.

OBJECTIVES: The objectives of this study were to establish the prevalence of positive antibodies to endomysium (EMA) and tissue transglutaminase (tTG) in children with type 1 diabetes living in Newfoundland and Labrador (NL), and to examine clinical features associated...

Cite
Pall H, Newhook LA, Aaron H, et al. Young Age at Diagnosis of Type 1 Diabetes Is Associated with the Development of Celiac Disease-Associated Antibodies in Children Living in Newfoundland and Labrador, Canada. Children (Basel). 2015;2(4):403-11doi: 10.3390/children2040403.
Pall, H., Newhook, L. A., Aaron, H., Curtis, J., & Randell, E. (2015). Young Age at Diagnosis of Type 1 Diabetes Is Associated with the Development of Celiac Disease-Associated Antibodies in Children Living in Newfoundland and Labrador, Canada. Children (Basel, Switzerland), 2(4), 403-11. https://doi.org/10.3390/children2040403
Pall, Harpreet, et al. "Young Age at Diagnosis of Type 1 Diabetes Is Associated with the Development of Celiac Disease-Associated Antibodies in Children Living in Newfoundland and Labrador, Canada." Children (Basel, Switzerland) vol. 2,4 (2015): 403-11. doi: https://doi.org/10.3390/children2040403
Pall H, Newhook LA, Aaron H, Curtis J, Randell E. Young Age at Diagnosis of Type 1 Diabetes Is Associated with the Development of Celiac Disease-Associated Antibodies in Children Living in Newfoundland and Labrador, Canada. Children (Basel). 2015 Oct 14;2(4):403-11. doi: 10.3390/children2040403. PMID: 27417372; PMCID: PMC4928772.
Copy Download .nbib Format: NLM
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.

Cancer investigation

Pagnano KB, Bendit I, Boquimpani C, De Souza CA, Miranda EC, Zalcberg I, Larripa I, Nardinelli L, Silveira RA, Fogliatto L, Spector N, Funke V, Pasquini R, Hungria V, Sérgio Chiattone C, Clementino N, Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlovsky MA, Cervera EE, Meillon LA, Simões B, Hamerschlak N, Bozzano AH, Mayta E, Cortes J, Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet RM.
PMID: 26279306
Cancer Invest. 2015 Aug 17; Epub 2015 Aug 17.

This is the largest Latin American study of BCR-ABL mutations in chronic myeloid leukemia (CML) patients, resistant to imatinib (IM). In 195/467 (41%) patients, mutations were detected. The most frequent mutation was T315I (n = 31, 16%). Progression-free (PFS)...

Cite
Pagnano KB, Bendit I, Boquimpani C, et al. BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival. Cancer Invest. 2015;
Pagnano, K. B., Bendit, I., Boquimpani, C., De Souza, C. A., Miranda, E. C., Zalcberg, I., Larripa, I., Nardinelli, L., Silveira, R. A., Fogliatto, L., Spector, N., Funke, V., Pasquini, R., Hungria, V., Sérgio Chiattone, C., Clementino, N., Conchon, M., Moiraghi, E. B., Lopez, J. L., Pavlovsky, C., Pavlovsky, M. A., Cervera, E. E., Meillon, L. A., Simões, B., Hamerschlak, N., Bozzano, A. H., Mayta, E., Cortes, J., & Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet, R. M. (2015). BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival. Cancer investigation, .
Pagnano, Katia Borgia Barbosa, et al. "BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival." Cancer investigation vol. (2015).
Pagnano KB, Bendit I, Boquimpani C, De Souza CA, Miranda EC, Zalcberg I, Larripa I, Nardinelli L, Silveira RA, Fogliatto L, Spector N, Funke V, Pasquini R, Hungria V, Sérgio Chiattone C, Clementino N, Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlovsky MA, Cervera EE, Meillon LA, Simões B, Hamerschlak N, Bozzano AH, Mayta E, Cortes J, Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet RM. BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival. Cancer Invest. 2015 Aug 17; Epub 2015 Aug 17. PMID: 26279306.
Copy Download .nbib Format: NLM
Bone metastases: Causes, consequences and therapeutic opportunities.

EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]

Perez-Garcia J, Muñoz-Couselo E, Cortes J.
PMID: 26217135
EJC Suppl. 2013 Sep;11(2):254-6. doi: 10.1016/j.ejcsup.2013.07.035.

No abstract available.

Cite
Perez-Garcia J, Muñoz-Couselo E, Cortes J. Bone metastases: Causes, consequences and therapeutic opportunities. EJC Suppl. 2013;11(2):254-6doi: 10.1016/j.ejcsup.2013.07.035.
Perez-Garcia, J., Muñoz-Couselo, E., & Cortes, J. (2013). Bone metastases: Causes, consequences and therapeutic opportunities. EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.], 11(2), 254-6. https://doi.org/10.1016/j.ejcsup.2013.07.035
Perez-Garcia, Jose, et al. "Bone metastases: Causes, consequences and therapeutic opportunities." EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] vol. 11,2 (2013): 254-6. doi: https://doi.org/10.1016/j.ejcsup.2013.07.035
Perez-Garcia J, Muñoz-Couselo E, Cortes J. Bone metastases: Causes, consequences and therapeutic opportunities. EJC Suppl. 2013 Sep;11(2):254-6. doi: 10.1016/j.ejcsup.2013.07.035. PMID: 26217135; PMCID: PMC4041187.
Copy Download .nbib Format: NLM
Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management.

Hematology (Amsterdam, Netherlands)

Ravandi-Kashani F, Cortes J, Kantarjian H, Talpaz M.
PMID: 27413879
Hematology. 1998;3(4):263-76. doi: 10.1080/10245332.1998.11746399.

Over the past two decades advances in the understanding of molecular and biological aspects of chronic myeloid leukemia (CML) have served as one of the cornerstones of progress in the management of leukemias, and more broadly of cancer in...

Cite
Ravandi-Kashani F, Cortes J, Kantarjian H, et al. Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management. Hematology. 1998;3(4):263-76doi: 10.1080/10245332.1998.11746399.
Ravandi-Kashani, F., Cortes, J., Kantarjian, H., & Talpaz, M. (1998). Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management. Hematology (Amsterdam, Netherlands), 3(4), 263-76. https://doi.org/10.1080/10245332.1998.11746399
Ravandi-Kashani, F, et al. "Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management." Hematology (Amsterdam, Netherlands) vol. 3,4 (1998): 263-76. doi: https://doi.org/10.1080/10245332.1998.11746399
Ravandi-Kashani F, Cortes J, Kantarjian H, Talpaz M. Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management. Hematology. 1998;3(4):263-76. doi: 10.1080/10245332.1998.11746399. PMID: 27413879.
Copy Download .nbib Format: NLM
Renormalizing Entanglement Distillation.

Physical review letters

Waeldchen S, Gertis J, Campbell ET, Eisert J.
PMID: 26824532
Phys Rev Lett. 2016 Jan 15;116(2):020502. doi: 10.1103/PhysRevLett.116.020502. Epub 2016 Jan 15.

Entanglement distillation refers to the task of transforming a collection of weakly entangled pairs into fewer highly entangled ones. It is a core ingredient in quantum repeater protocols, which are needed to transmit entanglement over arbitrary distances in order...

Cite
Waeldchen S, Gertis J, Campbell ET, et al. Renormalizing Entanglement Distillation. Phys Rev Lett. 2016;116(2):020502doi: 10.1103/PhysRevLett.116.020502.
Waeldchen, S., Gertis, J., Campbell, E. T., & Eisert, J. (2016). Renormalizing Entanglement Distillation. Physical review letters, 116(2), 020502. https://doi.org/10.1103/PhysRevLett.116.020502
Waeldchen, Stephan, et al. "Renormalizing Entanglement Distillation." Physical review letters vol. 116,2 (2016): 020502. doi: https://doi.org/10.1103/PhysRevLett.116.020502
Waeldchen S, Gertis J, Campbell ET, Eisert J. Renormalizing Entanglement Distillation. Phys Rev Lett. 2016 Jan 15;116(2):020502. doi: 10.1103/PhysRevLett.116.020502. Epub 2016 Jan 15. PMID: 26824532.
Copy Download .nbib Format: NLM
Trophic ecology of sea urchins in coral-rocky reef systems, Ecuador.

PeerJ

Cabanillas-Terán N, Loor-Andrade P, Rodríguez-Barreras R, Cortés J.
PMID: 26839748
PeerJ. 2016 Jan 14;4:e1578. doi: 10.7717/peerj.1578. eCollection 2016.

Sea urchins are important grazers and influence reef development in the Eastern Tropical Pacific (ETP). Diadema mexicanum and Eucidaris thouarsii are the most important sea urchins on the Ecuadorian coastal reefs. This study provided a trophic scenario for these...

Cite
Cabanillas-Terán N, Loor-Andrade P, Rodríguez-Barreras R, et al. Trophic ecology of sea urchins in coral-rocky reef systems, Ecuador. PeerJ. 2016;4:e1578doi: 10.7717/peerj.1578.
Cabanillas-Terán, N., Loor-Andrade, P., Rodríguez-Barreras, R., & Cortés, J. (2016). Trophic ecology of sea urchins in coral-rocky reef systems, Ecuador. PeerJ, 4e1578. https://doi.org/10.7717/peerj.1578
Cabanillas-Terán, Nancy, et al. "Trophic ecology of sea urchins in coral-rocky reef systems, Ecuador." PeerJ vol. 4 (2016): e1578. doi: https://doi.org/10.7717/peerj.1578
Cabanillas-Terán N, Loor-Andrade P, Rodríguez-Barreras R, Cortés J. Trophic ecology of sea urchins in coral-rocky reef systems, Ecuador. PeerJ. 2016 Jan 14;4:e1578. doi: 10.7717/peerj.1578. eCollection 2016. PMID: 26839748; PMCID: PMC4734443.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 859 entries